As of September 2024, BrightPath Biotherapeutics has a market cap of $21.41M. This makes BrightPath Biotherapeutics the world's 29458th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $28.13M | -22.99% |
2023 | $36.53M | -13.00% |
2022 | $41.98M | -10.71% |
2021 | $47.02M | -38.46% |
2020 | $76.41M | -41.85% |
2019 | $131.41M | 49.05% |
2018 | $88.17M | -66.98% |
2017 | $267.02M | -8.36% |
2016 | $291.37M | 162.88% |
2015 | $110.84M | - |